Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel

Information on individual lesion dynamics and organ location are often ignored in pharmacometric modeling analyses of tumor response. Typically, the sum of their longest diameters is utilized. Herein, a tumor growth inhibition model was developed for describing the individual lesion time‐course data...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Sreenath M., Laarif, Sofiene S., Bender, Brendan C., Quartino, Angelica L., Friberg, Lena E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129720/
https://www.ncbi.nlm.nih.gov/pubmed/33818899
http://dx.doi.org/10.1002/psp4.12629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129720/
https://www.ncbi.nlm.nih.gov/pubmed/33818899
http://dx.doi.org/10.1002/psp4.12629

Ejemplares similares